Aim: To study the antiviral effect of Oenanthe javanica flavones (OjF) on human hepatoma HepG2.2.15 culture system and duck hepatitis B virus (DHBV) infection. Methods: (1) After incubation for 24 h, the 2.2.15 cells were treated with different concentrations of OjF for 12 d. The cell alteration was observed by microscope. The presence of HBsAg and HBeAg were measured using the enzyme immunoassay kit after 2.2.15 cells were treated with OjF for 9 d. (2) Ducklings infected with DHBV intravenously were divided into 5 groups and treated with OjF, acyclovir (ACV), and normal saline respectively for 10 d. All the ducklings were bled before, during, and after treatments at different times, and serum levels of DHBV-DNA were detected by a dot-blot hybridization assay. Results: (1) The 50% toxic concentration (TC 50 ) of OjF was 2.28 g/L. The maximum nontoxic concentration (TC 0 ) was 1.00 g/L. In nontoxic concentrations, OjF significantly inhibited HBsAg and HBeAg in 2.2.15 cells after 9 d of treatment (P<0.05, P<0.01). (2) The DHBV-DNA levels decreased significantly after the treatment with 0.50 and 1.00 g/kg of OjF (P<0.01). The inhibition of the peak of viremia was maximum at a dose of 1.00 g/kg and reached 54.3% on d 5 and 64.5% on d 10, respectively. Conclusion: The results demonstrate that OjF is a strong inhibitor of HBsAg and HBeAg secretion in 2.2.15 cells and DHBV-DNA levels in the HBV-infected duck model.
Introduction
Oenanthe javanica (Oj), umbelliferate, has been widely used in traditional Chinese medicine for treatment of jaundice, hypertension, and polydipsia diseases for many years [1] . Previous studies have shown that it has liver-protective [2] , hypotensive [3] , anti-arrhythmic [4] , anti-anaphylactic [5] , and antidiabetic [6] effects. Recent studies also show that Oj was helpful in treatment of hepatitis B virus (HBV) infection in clinical trials [7] , and had an inhibitory effect on duck hepatitis B virus (DHBV)-induced hepatitis in Nestling ducks in vivo [8] and in vitro [9] . However, which is the active part and what are the active components of Oj in inhibiting HBV remain unclear. Using modern techniques, it has been revealed that OjF is one of the main active parts against HBV and it comprises approximately 2.2% of the whole plant content.
The present study aimed to investigate the anti-hepatitis activity of OjF in 2.2.15 cells in vitro and duck HBV infection in a duck model in vivo.
Materials and methods
Preparation of OjF Oj was collected from the Yanbian Autonomus Region in autumn and identification was performed by Prof Hui-zhong XIAO, Department of Phytochemistry, Yanbian Medical University. Dried whole plant was pulverized and extracted with 80% ethanol, and subsequently partitioned in ethyl acetate. The ethyl acetate soluble materials were fractionated by ethanol and distilled water gradient of column chromatography in polyamide. OjF was eluted and the content was determined according to aluminium nitrate reagent method. The content of hyperoside, the major ingredient of OjF, was determined by reverse phasehigh performance liquid chromatography (RP-HPLC) [10, 11] . The contents of OjF and hyperoside were 51.67% and 7% in whole extracts, respectively. The concentration used in the experiment was based on the dry weight of the extract.
Experimental Viremia analysis Viremia was assessed throughout the treatment and follow-up period by a semi-quantitative detection of DHBV-DNA in duck serum using a dot-blot hybridization. Fifty microliters of serum was spotted directly onto nitrocellulose filters. After denaturation and neutralization, the filters were hybridized with a full-length DHBV genomic DNA probe labeled with 32 P. The filters were autoradiographed and the spots were counted in a scintillation counter.
Histopathological examination of hepatocytes On d 13, each duckling was laparotomized to obtain the liver immediately after collecting blood from the leg vein. Fragments of the ducklings liver were fixed in 10% formalin solution, dehydrated with ethanol solution from 50% to 100%, embedded in paraffin and cut into 5 µm sections, and stained using haematoxylin-eosin dye for photomicroscopic observations.
Statistics The data were expressed as mean±SD, and analyzed by one-way repeated-measure ANOVA and t-test for comparisons between groups. P<0.05 was considered statistically significant.
Results
The cytotoxicity of OjF in 2.2.15 cells OjF-induced cytotoxicity was observed by microscope. After 12 d of incubation with 1.00 g/L OjF, no significant difference was found from that of the control. However, when OjF concentration increased, cell injury caused by OjF was observed ( Table 1) . The 50% toxic concentrations (TC 50 ) was 2.28±0.13 g/L and the maximum nontoxic concentrations (TC 0 ) was 1.00 g/L.
Inhibition of HBsAg and HBeAg production in 2.2.15 cells After 9 d of incubation, HBsAg and HBeAg production in the culture medium were determined ( Table 2 ). The results showed that OjF suppressed HBsAg and HBeAg production in the 2.2.15 cells with median effective concentration (IC 50 ) of about 0.56 and 0.41 g/L respectively on d 6, 0.64 and 0.30 g/L respectively on d 9 (Table 3) . OjF-induced suppression of HBsAg and HBeAg production in 2.2.15 cells was also reflected by the inhibition rate percentage (Figure 1, 2) . The inhibitory effects appeared when cells were treated with 0.25 g/L OjF. A substantial increase of inhibitory effects was observed from 0.50 g/L OjF. When treated with 1.00 g/L OjF, the inhibition rate percentage on HBsAg and HBeAg in 2.2.15 cells were both more than 50%. The inhibition rate percentage on HBsAg was dosedependent, and the inhibition rate percentage on HBeAg was both time-and dose-dependent.
Inhibitory effect of OjF on DHBV-DNA During the course of this study, no obvious side effects were observed in animals receiving antiviral therapy or in control animals.
The effects of OjF and ACV, which were used for comparison, on DHBV replication in vivo were determined . In the control group, serum DHBV-DNA remained unaffected during the course of the study.
Histopathological features Histopathological profiles of the liver from model group ducklings revealed necrosis, steatosis, and often swelling of the hepatic cytoplasm. The protective effect of OjF was confirmed by histopathological examinations. Administration of OjF to the experimental animals (1.00 g·kg -1 ·d -1 ) showed a significant improvement of the hepatocellular architecture over the model group, as evident from a considerable reduction in necrosis and vacuolation ( Figure 3 ).
Discussion
Hepatitis B virus causes acute and chronic hepatitis, which affects nearly 360 million people worldwide [12] . Chronic infection with HBV has been associated with a high risk for the development of primary hepatocellular carcinoma [13, 14] . Effective antiviral therapy against HBV infection has not been fully developed. Studies have been hampered by the extremely narrow host range and limited access to experimental culture systems. Fortunately, techniques have been developed to propagate hepadnaviridae in tissue culture [15, 16] and animal systems [17] . The 2.2.15 cells contain all HBV particles, and the Peking ducks allow multiplication of the HBV-like virus, which make it possible to study the various aspects of the viral life cycle and to examine the effectiveness of potential antiviral drugs.
In a previous study, we have shown that the acid-base extracts of Oj could protect hepatic cells, decrease the content of ALT, AST, and BiliT on a liver damage model caused by carbon tetrachloride (CCl 4 ) in rats [18] , and inhibit DHBV [7, 8] . Similar results of the inhibitory effect of Oj extracts on HBsAg and HBeAg production in cultured 2.2.15 cells was also observed [19] . However, what the active part of Oj against HBV is is still unknown. OjF was obtained through extraction and separation, which made up more than 50% in the whole extracts. It might be an active part against HBV.
Through subsequent purification of OjF, hyperoside, persicarin, isorhamnetin, and quercetin were obtained. Among them, the assay of hyperoside was the highest (purity>96%) , which was used as the criterion to control the quality of OjF.
This study demonstrated the inhibitory effect of OjF on HBsAg and HBeAg secretion by human hepatoma 2.2.15 cells and on serum DHBV-DNA levels of ducklings infected with hepatitis B virus. TC 50 of OjF was 2.28 g/L and TC 0 was 1.00 g/L in 2.2.15 cells, which suggested that the inhibitory action of OjF had no cytotoxicity. In nontoxic concentrations, OjF significantly inhibited the secretion of HBsAg and HBeAg. With OjF concentration increasing, a dose-dependent response was observed. At a TC 0 of 1.00 g/L, the inhibition rate percentage of OjF on HBsAg and HBeAg in 2.2.15 cells were both more than 50%, and the inhibition rate per- centage on HBsAg exceeded that of OjF on HBeAg.
These results clearly illustrate an inhibitory effect of OjF on HBsAg and HBeAg production in 2.2.15 cells, which provide strong evidence to evaluate the effect of drugs against HBV in a cellular model, but it is still necessary to verify this in an animal model. Therefore, the inhibitory effect of OjF in the duck HBV model was investigated. Our experiments with OjF (0.50 and 1.00 g·kg ·d -1 , the therapy caused a more pronounced decrease (64.5%) in viremia. It was well known that most antivirus medicines had the inevitable rebound effect after drug cessation. This shortcoming had limited the therapy to those diseases infected by viruses such as HB or AIDS. The similar phenomena appeared in the positive control drug ACV in the present study. OjF showed therapeutic effects as well as ACV, and no difference was observed after cessation of OjF therapy compared to OjF-treated animals. It suggested that OjF could maintain for a long time in treating viremia of HBV and the effect of DHBV-DNA inhibition showed a concentration-dependent response. Histopathological examination also confirmed the function of OjF protecting the liver in DHBV-infected ducklings. Xiong Q et al [19] reported that Apocynum ventun extracts containing hyperoside and quercetin had hepatoprotective activity, and OjF contained these two compounds. These results demonstrated the antihepatitis B virus effect of OjF, which were consistent with antiviral activity of Oj [7, 8] , making OjF a candidate for future evaluation in patients with HBV infection.
In order to elucidate the possible mechanism of OjF towards DHBV-DNA on DHBV-infected ducklings, the effect of OjF on DHBV-DNA was investigated (data not shown). Our results indicate that OjF might inhibit the DNA-dependent DNA polymerase reaction, which results in the termination of replication of DHBV-DNA. This hypothesis is currently under investigation in our laboratory.
In conclusion, OjF possessed the significant antiviral activity in vitro and in vivo, and it was one of the main active parts of Oj against HBV. Elucidation of the mechanism of its antiviral activity and identification of the active components in OjF will greatly enhance the understanding of viral gene expressions and provide new clues to assist in the development antiviral agents in the future.
